This according to researcher
According to researcher:
- Oxford vaccine shows good antibody,T-cell response
The shares of AstraZeneca jumps 9% on the headline news
The official report is scheduled to be released later today.
Archives of “Medical research” tag
rssGilead trial for Covid-19 meets primary endpoint
Push stocks higher
- Gilead Remdesivir trial for Covid-19 has met primary endpoint
- Study to provide info on 5-day duration of therapy
- will share added Remdesivir data from phase 3 shortly
- Seees data from 2nd simple study at the end of May